Key facts
- This page summarizes Mark B. Templeton's Form 4 filing for Health Catalyst, Inc. (HCAT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Jun 2023, 17:20.
Mark B. Templeton - 14 Jun 2023 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)
- Reporting relationship
- Director
- Issuer ticker
- HCAT
- Reported as of
- 14 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2023, 17:20:25 UTC
- Prior SEC filing
- 24 May 2023
- Next SEC filing
- 25 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/Benjamin Landry, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark B. Templeton filed Form 4 for Health Catalyst, Inc. (HCAT) on 16 Jun 2023.
Change
- Previous filing in this sequence was filed on 24 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HCAT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,359
- Change %
- +25%
- Price
- $0.000000
- Shares after
- 26,855
- Date
- 14 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
HCAT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,505
- Change %
- +47%
- Price
- $0.000000
- Shares after
- 39,360
- Date
- 14 Jun 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on each of September 1, 2023, December 1, 2023, March 1, 2024 and June 1, 2024.
Footnote F2
Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.